# Selenium and Arsenic Pharmacodynamics

> **NCT02377635** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 40 (actual)

## Conditions studied

- Arsenic Poisoning Chronic

## Interventions

- **DIETARY_SUPPLEMENT:** Anhydrous selenite
- **DIETARY_SUPPLEMENT:** Sodium chloride

## Key facts

- **NCT ID:** NCT02377635
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-10
- **Primary completion:** 2016-12-19
- **Final completion:** 2017-01-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-10-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02377635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02377635, "Selenium and Arsenic Pharmacodynamics". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02377635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*